Lecture 9: Drugs for Heart Failure Flashcards

1
Q

Catopril

What is its MOA, what 3 things is it used for (H/HF/DN), and what are its 3 major toxicities?

What are Enalapril, Benazepril, and Lisonopril?

A

MOA: competitive inhibitor of ACE blocking angiotensin II production = lower BP; used for hypertension, HFrEF, diabetic neuropathy

Toxicities: cough (number 1 reason for stopping), angioedema, FETAL TOXICITY

E: prodrug, active enalaprilat available for IV
B: widely used, longer 1/2 life (once daily dose)
L: widely used, longer 1/2 life (once daily dose)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Losartan

What is its MOA, what 3 things is it used for (H/HF/DN), and what its 3 major adverse effects?

What are Valsartan and Candesartan?

A

MOA: competitive NONpeptide Angiotensin II receptor antagonist for AT1 receptors, blocking vasoconstriction and aldosterone secretion; used for hypertension, HF if ACEi intolerant, and diabetic neuropathy

Toxicities: adverse effects more common in diabetics, cough (less than ACEi), and FETAL TOXICITY

V: not prodrug, excreted in FECES (pts. w/Liver failure)
C: ARB w/irreversible binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are 5 reasons NOT to administer ACE inhibitors/ARBS to patients with LV dysfunction? (T/P/H/SC/H)

A
  1. not tolerated (cough, angioedema –> use ARB)
  2. pregnant = FETAL TOXICITY
  3. hypotensive
  4. serum creatinine > 3 mg/dL
  5. hyperkalemia (OK up to 5.5 mEq/L)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Valsartan + Sacubitril

What is their MOA, what are they used, and are 4 common toxicities? (H/H/SC/A)

A

MOA: sacubitril blocks neutral endopeptidase (NEP) and prevents degradation of ANP; Valsartan is an ARB that is co-crystalized with sacubitril
- used for HEART FAILURE (inc. ANP/BNP lvls)

Toxicities: hypotension, hyperkalemia, inc. serum creatinine, angioedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Carvedilol

What is its MOA, what is it used for, and what is a major contraindication of use?

A

MOA: nonselective alpha/beta blocker (more beta) that is used in CLINICALLY STABLE pts. with HFrEF to prevent symptomatic HF

CI: do not abruptly withdraw Beta Blocker due to possible massive inc. in HR and BP

inverse agonist that helps keep the heart responsive to sympathetic drive (dysrhythmia protection)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ivabradine

What is its MOA, what is it used for, and who should it be used with?

A

MOA: inhibits If (Funny) channels within the SA node and prolongs diastole/slow HR; used to treat resting HR > 70 bpm in pts with stable symptomatic chronic HF

  • give to pts. on max tolerated beta blockers
  • give also if beta blockers are contraindicated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Spironolactone (eplerenone)

What is its MOA, what is it used for, and what are 3 common toxicities of use? (H/A/G)

A

MOA: competitive aldosterone receptor antagonist (K-sparing diuretic) that blocks aldosterone fibrosis effects and counteracts K loss induced by other diuretics

  • slow on and slow off effect

Toxicities: hyperkalemia, amenorrhea, gynecomastia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Furosemide (Loop Diuretic)

What is its MOA, what is it used for, and what are two major toxicities of use?

What is ethacrynic acid?

A

MOA: directly inhibits Na/K/2Cl cotransporter in thick ascending loop of Henle used to manage edema in HF pts. and hypertension (works in pts. with low GFR unlike Thiazides) with rapid IV onset

Toxicities: ototoxicity (vertigo, nystagmus) and sulfa hypersensitivity

ethacrynic acid can be used in pts. w/sulfa allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What two molecules are inc. in the urine of pts. taking Furosemide?

How should diuretics be used?

A

Calcium and Magnesium
- disruption of the NA/K/2Cl cotransporter in the Thick Ascending Limb blocks their passive movement across the cell

  • use Loop Diuretics FIRST, then add K-sparing diuretics if needed, and thiazide diuretics if STILL needing more diuresis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Nitroglycerin (isosorbide dinitrate)

What is its MOA, what is it used for, and what vasculature does it commonly affect?

A

MOA: forms free radical NO that inc. cGMP that dephosphorylates myosin light chain and causes SM relaxation
- affects VEINS more prominently

  • used for angina pectoris and acute decompensated HF
  • isosorbide dinitrate used for angina and HFrEF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hydralazine

What is its MOA, what is it used for, and what vasculature does it commonly affect?

What are some of its common toxicities? (A/P/DIL)

A

MOA: direct vasodilator of arterioles that decreases systemic resistance (hyperpolarizes, endo dependent) and is used for HTN, HFrEF in ACEi/ARB intolerance, and HTN emergency in pregnancy
- especially useful for African American pts.

Toxicities: angina pectoris, pruritis, drug-induced lupus-like syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Digoxin (Digitalis)

What is its MOA, what are its two major uses, and how does it affect pregnant patients?

A

MOA: inhibits NA/K ATPase pump in myocardial cells, causing inc. sodium/calcium exchange = inc. contractility

  • direct AV node conduction suppression
  • positive inotrophic effect

Use: control ventricles in pts with A Fib and HF
Pregnancy: crosses placenta; safe for use with supraventricular tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does Digoxin cause Cardiac Toxicity?

A
  • competes with K for binding to the Na/K ATPase pump, so if there is too little potassium in the pt, there will be TOO MUCH block
  • myocytes become overloaded with Calcium, coupled with SR release, cause delayed after-polarizations and aftercontractions = arrhythmias

uncouples the atria from the ventricles, making cardiomyocytes MORE prone to arrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does Digoxin toxicity look like on ECG?

What must a patient have before receiving Digoxin?

What visual disturbance do pts. taking Digoxin experience?

A
  • starts with A-V conduction problems, with lack of P and QRS relationship (dropped QRS waves)
  • can worsen to have ectopic ventricular beats (deep Q wave during ventricular depolarization) = BIGEMINY

pts must have NORMAL HR before digoxin administration

Visual: blurred, yellowish/greenish halos and tinge to objects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How are these ADHF patients treated:

  1. Hypertensive
  2. Normotensive
  3. Hypotensive
A
  1. treat with Loop Diuretic and Vasodilator
    • VD = nitroglycerin or nitroprusside
  2. treat with Loop Diuretic +/- Vasodilator
    • VD = nitroglycerin
  3. Hypotensive = treat with Loop Diuretic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When are Inotropic Agents indicated?

What are the two classes of Inotropic Agents that can be used?

A
  • indicated if symptomatic hypotension with end-organ failure DESPITE adequate filling pressure

Classes: Sympathomimetics (dobutamine and dopamine) and Type III PDEi (milrinone)

17
Q

Dobutamine

What is its MOA, what is it used for, and how is it administered?

A

MOA: racemic myocardial beta 1/2 receptor agonist that increases contractility and HR for short-term management of patients with cardiac decompensation

  • administered through IV
18
Q

Dopamine

What is its MOA, what is it used for, and how is it administered?

A

MOA: catecholamine that activates beta 1 receptors at low doses and stimulate alpha receptors at high doses; causes inc. HR and contractility in pts suffering from shock in cases of cardiac decompensation
- shock persisting after adequate fluid replacement

  • given IV, rapid acting
19
Q

Milrinone

What is its MOA, what is it used for, and how is it administered?

A

MOA: selective PDE III inhibitor leading to inc. cAMP causing inc. heart contractility and vasodilation in pts. unresponsive to other acute heart failure therapies

  • administered IV
20
Q

What are 3 drug groups that should be avoided in treatment of patients suffering from Acute Decompensated Heart Failure?

A

Class 1 antiarrhythmics (some negative inotropes)
Calcium Channel Blockers (suppress contractility)
NSAIDS (impair renal salt/water excretion)